Triptorelin Pamoate LAR Injection

Product introduction

Indication: Advanced prostate cancer, female infertility.
Storage: Sealed, protected from light and stored at 2-8℃.
Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin reversibly represses gonadotropin secretion. After chronic, continuous administration, Triptorelin Pamoate LAR Injection effects sustained decreases in LH and FSH production and testicular and ovarian steroidogenesis. Serum testosterone concentrations may fall to levels typically observed in surgically castrated men.